Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Total
Balance at beginning of period at Dec. 31, 2020	$ 57	$ 116,732	$ (9,817)	$ (7,855)	$ 99,117
Balance (in shares) at Dec. 31, 2020	5,663,040
Increase (Decrease) in Stockholders' Equity
Stock-based compensation expense		1,110			1,110
Exercise of stock options		442			442
Exercise of stock options (in shares)	25,201
Sale of common stock	$ 44	261,433			261,477
Sale of common stock (in shares)	4,370,277
Special dividend	$ 1	7,845	(11,250)		(3,404)
Special dividend (in shares)	125,212
Common stock dividends			(3,946)		(3,946)
Net income			14,144		14,144
Total other comprehensive income				4,945	4,945
Reclassification of warrants		12,192			12,192
Balance at end of period at Dec. 31, 2021	$ 102	399,754	(10,869)	(2,910)	386,077
Balance (in shares) at Dec. 31, 2021	10,183,730
Increase (Decrease) in Stockholders' Equity
Equity awards issued (in shares)	3,371
Stock-based compensation expense		1,492			1,492
Shares acquired to satisfy employee tax withholding requirements on stock awards		(23)			(23)
Shares acquired to satisfy employee tax withholding requirements on stock awards (in shares)	(285)
Exercise of stock options		147			147
Exercise of stock options (in shares)	5,600
Common stock dividends			(6,727)		(6,727)
Net income			6,110		6,110
Total other comprehensive income				10,193	10,193
Balance at end of period at Dec. 31, 2022	$ 102	$ 401,370	$ (11,486)	$ 7,283	$ 397,269
Balance (in shares) at Dec. 31, 2022	10,192,416